Drug intelligence / Profile preview

varicella-zoster virus vaccine (Shanghai Zerun Biotechnology Co., Ltd.)

Development stage
Unknown
Lead developer
Shanghai Zerun Biotechnology
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

This recombinant protein vaccine is being developed by Shanghai Zerun Biological for the prevention of varicella (chickenpox) and herpes zoster (shingles). The vaccine is based on recombinant varicella-zoster virus (VZV) antigens expressed using a Chinese Hamster Ovary (CHO) cell expression system. It works by inducing protective immune responses against VZV through the administration of these recombinant antigens. Currently in Phase 1 clinical development, the vaccine leverages Shanghai Zerun's platforms for recombinant protein expression and innovative adjuvant research.

Other names
水痘-带状疱疹病毒疫苗recombinant varicella-zoster virus vaccine

Beyond the preview

Go deeper on varicella-zoster virus vaccine (Shanghai Zerun Biotechnology Co., Ltd.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on varicella-zoster virus vaccine (Shanghai Zerun Biotechnology Co., Ltd.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call